Search

Your search keyword '"Webb TR"' showing total 167 results

Search Constraints

Start Over You searched for: Author "Webb TR" Remove constraint Author: "Webb TR"
167 results on '"Webb TR"'

Search Results

101. Combinatorial synthesis and biological evaluation of peptide-binding GPCR-targeted library.

102. Design and synthesis of a novel tyrosine kinase inhibitor template.

103. The ataxia protein sacsin is a functional co-chaperone that protects against polyglutamine-expanded ataxin-1.

104. MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family.

105. Accessory proteins are vital for the functional expression of certain G protein-coupled receptors.

106. Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy.

107. Distinct melanocortin 2 receptor accessory protein domains are required for melanocortin 2 receptor interaction and promotion of receptor trafficking.

108. Blue cone monochromacy: causative mutations and associated phenotypes.

109. The majority of adrenocorticotropin receptor (melanocortin 2 receptor) mutations found in familial glucocorticoid deficiency type 1 lead to defective trafficking of the receptor to the cell surface.

110. Activating mutations in ALK provide a therapeutic target in neuroblastoma.

111. Antitumor compounds based on a natural product consensus pharmacophore.

112. Diphthamide modification of eEF2 requires a J-domain protein and is essential for normal development.

113. The melanocortin 2 receptor accessory protein exists as a homodimer and is essential for the function of the melanocortin 2 receptor in the mouse y1 cell line.

114. Generation of new synthetic scaffolds using framework libraries selected and refined via medicinal chemist synthetic expertise.

115. Pulmonary toxicity screening studies in male rats with M5 respirable fibers and particulates.

116. Application of a novel design paradigm to generate general nonpeptide combinatorial templates mimicking beta-turns: synthesis of ligands for melanocortin receptors.

117. Why does Kevlar decompose, while Nomex does not, when treated with aqueous chlorine solutions?

118. Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties.

119. Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics.

120. Polymer-supported synthesis of pyridone-focused libraries as inhibitors of anaplastic lymphoma kinase.

121. Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and surface area.

122. Design and synthesis of 5-aryl-pyridone-carboxamides as inhibitors of anaplastic lymphoma kinase.

123. Biodegradability of para-aramid respirable-sized fiber-shaped particulates (RFP) in human lung cells.

124. Comparative pulmonary toxicity inhalation and instillation studies with different TiO2 particle formulations: impact of surface treatments on particle toxicity.

125. Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappaB-dependent mechanism of p53 suppression in tumors.

126. Current directions in the evolution of compound libraries.

127. Bonding along a linear B...N...B triad.

128. Design of 2,5-dimethyl-3-(6-dimethyl-4-methylpyridin-3-yl)-7-dipropylaminopyrazolo[1,5-a]pyrimidine (NBI 30775/R121919) and structure--activity relationships of a series of potent and orally active corticotropin-releasing factor receptor antagonists.

129. Novel asymmetric approach to proline-derived spiro-beta-lactams.

130. Synthesis of benzoylpyrimidines as antagonists of the corticotropin-releasing factor-1 receptor.

132. Solid-phase synthesis of tetrahydro-1,4-benzodiazepine-2-one derivatives as a beta-turn peptidomimetic library.

133. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats.

134. Pulmonary toxicity studies in rats with triethoxyoctylsilane (OTES)-coated, pigment-grade titanium dioxide particles: bridging studies to predict inhalation hazard.

135. Application of a novel design paradigm to generate general nonpeptide combinatorial scaffolds mimicking beta turns: synthesis of ligands for somatostatin receptors.

136. Four-week inhalation toxicity study in rats with nylon respirable fibers: rapid lung clearance.

137. Synthesis and SAR of 8-arylquinolines as potent corticotropin-releasing factor1 (CRF1) receptor antagonists.

138. Assessing the role of neutrophil apoptosis in the resolution of particle-induced pulmonary inflammation.

140. Synthesis of purine- and pyrimidine-substituted heptadienes. The stereochemistry of cyclization and cyclopolymerization products.

141. Quinazolines as adenosine receptor antagonists: SAR and selectivity for A2B receptors.

142. Coordination chemistry of silver(I) with the nitrogen-bridged ligands (C(6)H(5))(2)PN(H)P(C(6)H(5))(2) and (C(6)H(5))(2)PN(CH(3))P(C(6)H(5))(2): the effect of alkylating the nitrogen bridge on ligand bridging versus chelating behavior.

143. Biodegradability of inhaled p-aramid respirable fiber-shaped particulates (RFP): mechanisms of RFP shortening and evidence of reversibility of pulmonary lesions.

145. Biodegradability of inhaled para-aramid respirable-sized fiber-shaped particulates: mechanistic in vivo and in vitro studies.

146. Man-made respirable-sized organic fibers: what do we know about their toxicological profiles?

147. Biodegradability of inhaled p-aramid respirable fibre-shaped particulates: representative of other synthetic organic fibre-types?

148. The utilization of a unified pharmacophore query in the discovery of new antagonists of the adenosine receptor family.

149. Time Course of Eosinophilic Recruitment and Pulmonary Toxicity Biomarkers in an Allergic Asthma Model in Brown Norway Rats.

150. Sulfuranes Lacking Benzoannelation. Sulfuranes and Other Hypervalent Molecules Studied by (17)O-NMR.

Catalog

Books, media, physical & digital resources